https://akronbiotech.com/ 2026-05-18T16:48:32+00:00 1.00 https://akronbiotech.com/product/all 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/product/cytokines-growth-factors 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/product/human-plasma-derived-products 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/product/other-media-supplements 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/product/css 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/quality/all 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/quality/our-quality-principles 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/quality/regulatory-support 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/quality/documents-and-certificates 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/custom-services/all 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/custom-services/protein-nuclease-development-manufacturing 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/custom-services/media-development-manufacturing 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/custom-services/transfection-transduction-reagents 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/knowledge-center/all 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/knowledge-center/blog 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/knowledge-center/past-events 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/knowledge-center/posters-publications 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/about/all 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/about/the-akron-difference 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/about/partnerships 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/about/executive-leadership 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/about/newsroom 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/about/upcoming-events 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/about/careers 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/contact-us 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/product/il21-css 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/icgm-phenol-red 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/critical-raw-materials-elevated 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/newsroom/qkine-limited-and-akron-bio-announce-strategic-partnership 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/newsroom/terumo-blood-and-cell-technologies-and-akron-bio-complete-collaborative-study-on-msc-expansion-using-quantum-flex 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/newsroom/charles-river-and-akron-bio-announce-collaboration-to-enhance-operations-with-integration-of-cgmp-materials-into-cell-therapy-platform 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/newsroom/multiply-labs-and-akron-bio-partner-to-automate-the-use-of-cgmp-compliant-liquid-cytokines-in-cell-therapy-manufacturing 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/our-patents 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/privacy-policy 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/terms-of-use 2026-05-18T16:48:32+00:00 0.80 https://akronbiotech.com/product/il2-css 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/recombinant-human-interleukin-2-rhu-il-2-prefilled-syringe 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/recombinant-human-interleukin-2-rhu-il-2 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/il7-css 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/recombinant-human-interleukin-7-rhu-il-7 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/recombinant-human-interleukin-12-rhu-il-12-new 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/il15-css 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/recombinant-human-interleukin-15-rhu-il-15 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/recombinant-human-interleukin-18-rhu-il-18-new 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/recombinant-human-interleukin-21-rhu-il-21 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/recombinant-human-erythropoietin-rhu-epo 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/recombinant-human-granulocyte-colony-stimulating-factor-rhu-g-csf 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/recombinant-human-basic-fibroblast-growth-factor-155-rhu-bfgf-155 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/recombinant-human-platelet-derived-growth-factor-bb-rhu-pdgf-bb 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/human-ab-serum-converted-from-plasma-css 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/human-ab-serum 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/human-serum-albumin-25-css 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/human-serum-albumin-solution-25 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/human-fibronectin-solution-virus-inactivated 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/icgm-phenol-red-free 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/icgm-phenol-red-free-css 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/icgm-2 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/cryosolve 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/product/heparin-sodium-salt 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/assets/files/2026.01.11-Akron-Biotech-Single-Site-ISO-13485-2016-SM.pdf 2026-03-26T19:24:22+00:00 0.64 https://akronbiotech.com/blog/reducing-the-complexity-time-risk-and-cost-of-media-formulation-in-cell-therapy-manufacturing 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/blog/comparable-advantages-of-il-2-ancillary-material-use-over-pharmaceutical-reagents-within-cell-therapy-manufacturing 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/blog/mitigating-unintentional-effects-of-pharmaceutical-human-serum-albumin-preparations-in-therapeutic-cell-culture 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/blog/enhancing-the-safety-of-virus-inactivated-ancillary-materials-through-neutralizing-antibodies 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/blog/going-green-the-akron-way 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/blog/reducing-variability-in-cytokine-activity-reporting 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/blog/safety-first-methods-of-virus-inactivation-for-increased-safety-of-advanced-therapies 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/blog/cryopreservation-during-the-holidays 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/blog/building-a-resilient-cell-and-gene-therapy-industry-in-the-face-of-covid-19 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/blog/the-importance-of-cytokine-and-growth-factor-purity-in-cell-therapy-development-and-manufacturing 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/blog/building-a-robust-supply-chain-to-enable-cell-and-gene-therapy-development 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/blog/superiority-non-inferiority-and-equivalence-the-phase-iii-question 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/knowledge-center/blog/p2 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/knowledge-center/blog/p3 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/assets/files/Animal-Origin-free-Yeast-and-Soytone-based-Fed-Batch-Fermentation-as-a-Versatile-Platform-for-High-Yield-Plasmid-Production.pdf 2025-05-19T16:36:11+00:00 0.64 https://akronbiotech.com/assets/files/Dual-Cation-Exchange-Coupled-with-Multi-Modal-Chromatography-Allows-the-Production-of-High-Purity-and-Low-Residuals-cGMP-Grade-Cas9-Nuclease-for-Cell-Therapy-Applications.pdf 2025-05-13T13:19:05+00:00 0.64 https://akronbiotech.com/assets/files/Optimized-Homogenization-Matrix.pdf 2024-11-08T14:14:59+00:00 0.64 https://akronbiotech.com/assets/files/Highly-Stable-Liquid-IL-7-and-IL-15-Closed-System-Solutions.pdf 2024-11-08T14:14:57+00:00 0.64 https://akronbiotech.com/knowledge-center/posters-publications/p2 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/newsroom/akron-biotech-signs-exclusive-global-agreement-with-octapharma-to-produce-virally-inactivated-human-ab-serum-derived-from-octaplas-for-the-cell-therapy-market 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/newsroom/akron-bio-receives-eligibility-confirmation-from-pmda-in-japan-for-the-commercialization-of-virus-inactivated-human-fibronectin-in-clinical-cell-therapy-manufacturing 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/newsroom/meeting-the-increasing-manufacturing-demands-of-the-rapidly-growing-cell-and-gene-therapy-and-vaccine-markets-upcoming-webinar-hosted-by-xtalks 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/about/newsroom/p2 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/about/newsroom/p3 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/about/newsroom/p4 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/about/upcoming-events/p2 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/tax-information-request 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/request-for-support 2026-05-18T16:48:32+00:00 0.64 https://akronbiotech.com/assets/files/AR1056-SDS-rHu-IL-21-CSS.pdf 2026-05-05T17:36:30+00:00 0.64 https://akronbiotech.com/assets/files/AR1056-rHu-IL21-CSS-Product-Page.pdf 2026-05-04T15:34:54+00:00 0.64 https://akronbiotech.com/assets/files/AR1056-rHu-IL-21-CSS-MOU.pdf 2026-05-04T14:46:09+00:00 0.64 https://akronbiotech.com/assets/files/AR1056-rHu-IL21-CSS-FAQ.pdf 2026-05-04T14:46:30+00:00 0.64 https://akronbiotech.com/assets/files/AR1045-SDS-rHu-IL-2-CSS.pdf 2025-09-26T14:59:54+00:00 0.51 https://akronbiotech.com/assets/files/AR1045-AR1050-Product-Page-Recombinant-Human-Interleukin-2-rHu-IL-2-Closed-System-Solutions-CSS.pdf 2026-01-19T17:58:35+00:00 0.51 https://akronbiotech.com/assets/files/AR1045-AR1050-MoU-Recombinant-Human-Interleukin-2-rHu-IL-2-Closed-System-Solutions-CSS.pdf 2025-10-30T17:42:04+00:00 0.51 https://akronbiotech.com/assets/files/AR1045-AR1050-FAQ-Recombinant-Human-Interleukin-2-rHu-IL-2-Closed-System-Solutions-CSS.pdf 2025-10-30T17:52:49+00:00 0.51 https://akronbiotech.com/assets/files/AK8223-rHu-IL-2-tech-overview_final.pdf 2021-07-15T18:06:44+00:00 0.51 https://akronbiotech.com/assets/files/AK9984-SDS-Recombinant-Human-Interleukin-2-rHu-IL-2-Prefilled-Syringe.pdf 2021-07-09T00:54:55+00:00 0.51 https://akronbiotech.com/assets/files/AK9984-rHu-IL-2-Syringe-Product-Page-16Dec24.pdf 2026-01-19T17:58:35+00:00 0.51 https://akronbiotech.com/assets/files/AK9984-rHu-IL-2-syringe-FAQ.pdf 2024-12-20T20:10:17+00:00 0.51 https://akronbiotech.com/assets/files/AK8223-SDS-Recombinant-Human-Interleukin-2-rHu-IL-2.pdf 2022-11-28T18:32:10+00:00 0.51 https://akronbiotech.com/assets/files/AK8223-Product-Page-Recombinant-Human-Interleukin-2-rHu-IL-2.pdf 2026-01-19T17:58:33+00:00 0.51 https://akronbiotech.com/assets/files/AK8223-rHu-IL-2-FAQ_final.pdf 2021-07-15T18:06:00+00:00 0.51 https://akronbiotech.com/newsroom/the-medicine-makers-power-list-2021-honors-akron-biotech-ceo-dr-claudia-zylberberg 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/newsroom/akron-biotech-submits-ectd-drug-master-file-for-il-2-with-the-fda 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/assets/files/AR1013-SDS-rHu-IL-7-CSS.pdf 2024-05-16T17:27:21+00:00 0.51 https://akronbiotech.com/assets/files/AR1013-Product-page-rHu-IL-7-CSS-16Dec24.pdf 2026-01-19T17:58:35+00:00 0.51 https://akronbiotech.com/assets/files/AR1013-Product-page-rHu-IL-7-CSS-MOU.pdf 2024-12-31T15:29:39+00:00 0.51 https://akronbiotech.com/assets/files/AK9842-SDS-rHu-IL-7.pdf 2025-02-26T21:20:02+00:00 0.51 https://akronbiotech.com/assets/files/AK9842-Product-Page-Recombinant-Human-Interleukin-7-rHu-IL-7.pdf 2026-01-19T17:58:34+00:00 0.51 https://akronbiotech.com/assets/files/AK9842-rHu-IL-7-FAQ_final.pdf 2021-07-09T00:56:00+00:00 0.51 https://akronbiotech.com/assets/files/AR1051-SDS-Recombinant-Human-Interleukin-12-rHu-IL-12.pdf 2024-03-04T18:37:27+00:00 0.51 https://akronbiotech.com/assets/files/AR1051-Product-Page-Recombinant-Human-Interleukin-12-rHu-IL-12.pdf 2026-01-19T17:58:32+00:00 0.51 https://akronbiotech.com/assets/files/AR1051-FAQ-Recombinant-Human-Interleukin-12-rHu-IL-12.pdf 2024-04-15T21:18:18+00:00 0.51 https://akronbiotech.com/assets/files/AR1003-SDS-rHu-IL-15-CSS.pdf 2025-01-03T20:06:41+00:00 0.51 https://akronbiotech.com/assets/files/AR1003-Product-Page-rHu-IL-15-CSS-16Dec24.pdf 2026-01-19T17:58:35+00:00 0.51 https://akronbiotech.com/assets/files/AR1003-Product-page-rHu-IL-15-CSS-MOU.pdf 2024-12-31T15:29:38+00:00 0.51 https://akronbiotech.com/assets/files/AK9823-SDS-rHu-IL-15.pdf 2025-02-26T21:20:03+00:00 0.51 https://akronbiotech.com/assets/files/AK9823-Product-Page-Recombinant-Human-Interleukin-15-rHu-IL-15.pdf 2026-01-19T17:58:34+00:00 0.51 https://akronbiotech.com/assets/files/AK9823-rHu-IL-15-FAQ_final.pdf 2021-07-08T03:15:14+00:00 0.51 https://akronbiotech.com/assets/files/AR1052-SDS-Recombinant-Human-Interleukin-18-rHu-IL-18.pdf 2024-03-04T18:37:28+00:00 0.51 https://akronbiotech.com/assets/files/AR1052-Product-Page-Recombinant-Human-Interleukin-18-rHu-IL-18.pdf 2026-01-19T17:58:32+00:00 0.51 https://akronbiotech.com/assets/files/AR1052-FAQ-Recombinant-Human-Interleukin-18-rHu-IL-18.pdf 2024-04-15T21:18:30+00:00 0.51 https://akronbiotech.com/assets/files/AK9833-SDS-rHu-IL-21.pdf 2025-02-26T21:20:04+00:00 0.51 https://akronbiotech.com/assets/files/AK9833-Product-Page-Recombinant-Human-Interleukin-21-rHu-IL-21.pdf 2026-01-19T17:58:34+00:00 0.51 https://akronbiotech.com/assets/files/AK9833-rHu-IL-21-FAQ_final.pdf 2021-07-08T03:18:00+00:00 0.51 https://akronbiotech.com/assets/files/AK9941-SDS-Recombinant-Human-Erythropoietin-rHu-EPO.pdf 2021-07-09T01:47:12+00:00 0.51 https://akronbiotech.com/assets/files/AK9941-EPO-Product-page_final.pdf 2026-01-19T17:58:33+00:00 0.51 https://akronbiotech.com/assets/files/AK8248-SDS-Recombinant-Human-Granulocyte-Colony-Stimulating-Factor-rHu-G-CSF.pdf 2021-07-08T21:05:18+00:00 0.51 https://akronbiotech.com/assets/files/AK8248-rHu-G-CSF-Product-page_final.pdf 2026-01-19T17:58:33+00:00 0.51 https://akronbiotech.com/assets/files/AK9784-Product-Page-Recombinant-Human-Basic-Fibroblast-Growth-Factor-155-rHu-bFGF-155.pdf 2026-01-21T16:11:00+00:00 0.51 https://akronbiotech.com/assets/files/AK8274-Product-Page-Recombinant-Human-Platelet-Derived-Growth-Factor-BB-rHu-PDGF-BB.pdf 2026-01-21T16:11:00+00:00 0.51 https://akronbiotech.com/assets/files/AR1048-Product-Page-viHABS-CSS-Converted-from-Octaplas-v2.pdf 2026-01-19T17:58:32+00:00 0.51 https://akronbiotech.com/assets/files/AR1048-Octaplas-viHABS-CSS-MoU-003.pdf 2025-11-03T17:49:15+00:00 0.51 https://akronbiotech.com/assets/files/AR1048-Octaplas-viHABS-CSS-FAQ.pdf 2025-07-11T14:47:55+00:00 0.51 https://akronbiotech.com/assets/files/AR1010-SDS-vi-AB-Serum.pdf 2023-01-10T16:14:34+00:00 0.51 https://akronbiotech.com/assets/files/AR1010-Product-Page-viAB-Serum-2.pdf 2026-01-21T16:10:51+00:00 0.51 https://akronbiotech.com/assets/files/AB-SerumOctaplas-AR1010-0100-FAQ.pdf 2025-07-11T14:47:54+00:00 0.51 https://akronbiotech.com/assets/files/AR1037-SDS.pdf 2024-04-08T19:13:27+00:00 0.51 https://akronbiotech.com/assets/files/AR1037-Product-Page-HSA-25-CSS-v2.pdf 2026-01-19T17:58:33+00:00 0.51 https://akronbiotech.com/assets/files/AR1037-HSA-25-MOU.pdf 2025-03-06T20:49:27+00:00 0.51 https://akronbiotech.com/assets/files/AR1037-HSA-25-Solution-CSS-FAQ.pdf 2025-03-06T20:49:28+00:00 0.51 https://akronbiotech.com/assets/files/AK8228-SDS-HSA.pdf 2025-02-26T21:14:07+00:00 0.51 https://akronbiotech.com/assets/files/AK8228-0100-HSA-25-Solution-Product-page.pdf 2026-01-19T17:58:32+00:00 0.51 https://akronbiotech.com/assets/files/AK8228-HSA-25-Solution-FAQ_final.pdf 2021-07-09T03:11:20+00:00 0.51 https://akronbiotech.com/assets/files/AK9930-SDS-Human-Fibronectin-Solution-Virus-Inactivated.pdf 2025-02-25T19:52:37+00:00 0.51 https://akronbiotech.com/assets/files/AK9930-Product-Page-Human-Fibronectin-Solution-Virus-Inactivated.pdf 2026-01-19T17:58:34+00:00 0.51 https://akronbiotech.com/assets/files/AK9930-FAQ-Human-Fibronectin-Solution-Virus-Inactivated.pdf 2025-03-05T17:52:47+00:00 0.51 https://akronbiotech.com/assets/files/AK9930-MoU-Human-Fibronectin-Solution-Virus-Inactivated.pdf 2025-03-05T17:52:48+00:00 0.51 https://akronbiotech.com/assets/files/AK9989-SDS-ImmunoCell-Growth-Medium-ICGM-Phenol-Red-Free.pdf 2026-01-23T15:14:46+00:00 0.51 https://akronbiotech.com/assets/files/AK9989-Product-Page-ICGM-Phenol-Red-Free.pdf 2026-01-23T15:15:14+00:00 0.51 https://akronbiotech.com/assets/files/AK9989-FAQ-ICGM-Phenol-Red-Free.pdf 2026-01-23T15:15:30+00:00 0.51 https://akronbiotech.com/assets/files/AK9988-SDS-ImmunoCell-Growth-Medium-ICGM-Phenol-Red-Free-Closed-System-Solutions-CSS.pdf 2026-01-23T15:03:53+00:00 0.51 https://akronbiotech.com/assets/files/AK9988-Product-Page-ICGM-Phenol-Red-Free-CSS.pdf 2026-01-23T15:05:26+00:00 0.51 https://akronbiotech.com/assets/files/AK9988-MoU-ICGM-Phenol-Red-Free-CSS.pdf 2026-01-26T13:48:39+00:00 0.51 https://akronbiotech.com/assets/files/AK9988-FAQ-ICGM-Phenol-Red-Free-CSS.pdf 2026-01-23T15:05:56+00:00 0.51 https://akronbiotech.com/assets/files/AK9985-SDS-ImmunoCell-Growth-Medium-ICGM.pdf 2024-05-29T12:35:55+00:00 0.51 https://akronbiotech.com/assets/files/AK9985-Product-Page-ImmuoCell-Growth-Medium-ICGM.pdf 2025-06-16T16:51:45+00:00 0.51 https://akronbiotech.com/assets/files/AK9985-FAQ-ImmuoCell-Growth-Medium-ICGM.pdf 2025-06-16T16:51:45+00:00 0.51 https://akronbiotech.com/assets/files/AK8217-SDS-CryoSolve.pdf 2021-07-09T04:34:54+00:00 0.51 https://akronbiotech.com/assets/images/AK8217-Product-Page-CryoSolve.pdf 2026-04-27T18:17:58+00:00 0.51 https://akronbiotech.com/assets/files/AK9987-SDS-Heparin-Sodium-Salt.pdf 2025-03-06T22:17:59+00:00 0.51 https://akronbiotech.com/assets/files/AK9987-Product-Page-Heparin-Sodium-Salt.pdf 2026-01-19T17:58:33+00:00 0.51 https://akronbiotech.com/assets/files/AK9987-Heparin-Sodium-Salt-FAQ_final.pdf 2021-07-09T04:28:01+00:00 0.51 https://akronbiotech.com/blog/animal-derived-component-free-ancillary-materials-balancing-safety-and-risk 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/blog/stoichiometry-via-mass-spectrometry-sheds-light-on-the-t-cell-metabolism 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/blog/the-challenge-of-raw-material-variability-and-strategies-for-standardization 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/blog/driving-innovation-lowering-cost-of-goods-through-improved-customer-management 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/blog/assurance-and-control-two-sides-of-the-quality-coin 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/blog/aseptic-processing-to-maintain-the-integrity-of-ancillary-materials-for-cell-therapy-manufacturing 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/blog/advancements-in-biomedical-engineering-developing-hydrogels-for-tissue-regeneration-and-drug-delivery 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/blog/dmso-induces-drastic-changes-in-human-cellular-processes-and-epigenetic-landscape-in-vitro 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/blog/human-derived-plasma-ancillary-materials-for-cell-therapies-what-virus-inactivation-methods-should-you-consider 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/blog/manufacturing-scale-up 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/blog/incoterms-and-ancillary-materials-navigating-the-global-marketplace 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/blog/the-microscopic-cell-culture-plague-mycoplasma 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/blog/dr-zylberberg-is-recognized-as-a-leader-in-the-cell-and-gene-therapy-industry 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/blog/the-importance-of-standards-and-manufacturing-needs-recent-meetings 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/blog/exosomes-as-promising-vehicles-for-drug-delivery-to-the-brain 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/blog/new-methods-to-improve-cryopreservation-for-immunotherapies-using-a-bioinspired-solution 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/blog/cgmp-for-ancillary-materials-gaining-clarity-as-we-advance 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/blog/scb-perspectives-iso-publishes-three-part-documentary-standard-on-ancillary-materials-for-cell-manufacturing-processes 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/assets/files/Development-and-Evaluation-of-ImmunoCellTM-Growth-Medium.pdf 2024-11-08T14:14:55+00:00 0.51 https://akronbiotech.com/assets/files/Developing-Fed-Batch-Strategy.pdf 2024-11-08T14:14:53+00:00 0.51 https://akronbiotech.com/newsroom/de-risking-the-manufacturing-of-cell-therapies-through-virus-inactivated-products-upcoming-webinar-hosted-by-xtalks 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/newsroom/akron-biotech-signs-agreement-with-synairgen-plc-to-supply-interferon-beta-for-covid-19-treatment 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/newsroom/akron-submits-ectd-drug-master-files-with-fda-for-its-suite-of-cgmp-immunotherapy-cytokines 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/newsroom/akron-biotech-expands-to-second-us-manufacturing-facility 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/newsroom/akron-biotechnology-publishes-industry-wide-recommendations-for-the-regulation-of-ancillary-materials-for-atmp-manufacturing 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/newsroom/akron-biotechnology-joins-niimbl-workforce-development-grant-led-by-the-texas-a-m-engineering-experiment-station 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/newsroom/natural-killer-cells-progress-and-promise-upcoming-webinar-hosted-by-xtalks 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/newsroom/akron-bioproducts-announces-launch-of-its-closed-system-solutions-line-to-enable-seamless-integration-of-cgmp-ancillary-materials-in-cell-and-gene-therapy-manufacturing 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/newsroom/akron-bio-expands-commercialization-of-advanced-gene-therapy-and-vaccine-production-with-new-manufacturing-facility 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/newsroom/akron-bioproducts-and-vor-bio-to-collaborate-on-the-development-and-cgmp-manufacture-of-nucleases 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/newsroom/akron-biotech-ceo-dr-claudia-zylberberg-named-on-the-medicine-makers-power-list-2020 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/newsroom/akron-biotechnology-worcester-polytechnic-institute-collaboration-awarded-armi-grant 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/newsroom/claudia-zylberberg-akron-ceo-joins-the-arm-foundation-for-cell-gene-medicine-board-of-directors 2026-05-18T16:48:32+00:00 0.51 https://akronbiotech.com/newsroom/akron-biotech-flourishes-in-2017 2026-05-18T16:48:32+00:00 0.51